MAPPING THE MYELOMA GENOME
Learn about the MMRF’s leadership in multiple myeloma genomics and how this research can lead to improved patient care.
By working side by side with our researchers and clinicians and our partners in the biotech and pharmaceutical industry, we have helped bring patients four new treatments that have increased the survival of myeloma patients from four years to seven. Click here to learn more.
Our scientific agenda – with its focus on basic science, validation, and clinical trials – allows us to move drug development forward – faster. Click here to learn more.
The MMRF is excited to announce its newest initiative, the MMRF CoMMpass Study. This long term study will use principles of personalized medicine to generate hypotheses that may lead to new treatments for multiple myeloma, ultimately charting a course to a cure.
FOR ACADEMIC RESEARCHERS
As the leading funder of multiple myeloma research, the MMRF offers several prestigious high-value research grants to researchers at all levels of their career. Click here to learn more.
The MMRF is working closely with partners in the pharmaceutical and biotech industry to advance the next generation of treatments. Click here to learn more.